<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2019-5-4-0-2</article-id><article-id pub-id-type="publisher-id">1834</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>Association of the mitochondrial DNA haplogroup H1 variants with the risk of acute cardiovascular events</article-title><trans-title-group xml:lang="en"><trans-title>Association of the mitochondrial DNA haplogroup H1 variants with the risk of acute cardiovascular events</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Golubenko</surname><given-names>Maria V.</given-names></name><name xml:lang="en"><surname>Golubenko</surname><given-names>Maria V.</given-names></name></name-alternatives><email>maria.golubenko@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Babushkina</surname><given-names>Nadezhda P.</given-names></name><name xml:lang="en"><surname>Babushkina</surname><given-names>Nadezhda P.</given-names></name></name-alternatives><email>nad.babushkina@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zarubin</surname><given-names>Aleksei A.</given-names></name><name xml:lang="en"><surname>Zarubin</surname><given-names>Aleksei A.</given-names></name></name-alternatives><email>aleksei.zarubin@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Salakhov</surname><given-names>Ramil R.</given-names></name><name xml:lang="en"><surname>Salakhov</surname><given-names>Ramil R.</given-names></name></name-alternatives><email>ramil.salakhov@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Makeeva</surname><given-names>Oksana A.</given-names></name><name xml:lang="en"><surname>Makeeva</surname><given-names>Oksana A.</given-names></name></name-alternatives><email>oksana.makeeva@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Markova</surname><given-names>Valentina V.</given-names></name><name xml:lang="en"><surname>Markova</surname><given-names>Valentina V.</given-names></name></name-alternatives><email>markovavalentinav@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Afanasiev</surname><given-names>Sergei A.</given-names></name><name xml:lang="en"><surname>Afanasiev</surname><given-names>Sergei A.</given-names></name></name-alternatives><email>tursky@cardio-tomsk.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ponasenko</surname><given-names>Anastasia V.</given-names></name><name xml:lang="en"><surname>Ponasenko</surname><given-names>Anastasia V.</given-names></name></name-alternatives><email>ponaav@kemcardio.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Puzyrev</surname><given-names>Valery P.</given-names></name><name xml:lang="en"><surname>Puzyrev</surname><given-names>Valery P.</given-names></name></name-alternatives><email>p.valery@medgenetics.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/4/Биомедицинские_исслеования_4_219-20-32.pdf" /><abstract xml:lang="ru"><p>Background: Mitochondria play a major role in providing cells with energy, but at the same time they are a source of free radicals that increase oxidative stress. It is known that the mitochondrial DNA genotype can affect the efficiency of oxygen uptake and ATP synthesis. In previous studies, it was shown that haplogroup H1 mtDNA may be a risk factor for the development of life-threatening conditions in cardiovascular diseases. The aim of the study: To identify mtDNA variants of the haplogroup H1 affecting the risk of acute cardiovascular events. Materials and methods: The complete sequence of mtDNAs belonging to the H1 haplogroup was sequenced in two groups: (1) individuals who died of heart disease before the age of 55 years, or who had repeated myocardial infarction or heart failure progression within one year of follow-up after myocardial infarction; (2) individuals over 60 years without symptoms of cardiovascular disease, or sutviving to 90 years. MtDNA haplotypes were revealed and classified by belonging to H1 subhaplogroups. Median-joining network was constructed in the program Network v5.0. Results: 13 different H1 subhaplogroups were identified in the studied samples. In the group with acute cardiovascular events, the incidence of T16189C polymorphism was 18.75%, compared with a sample of long-livers and individuals without symptoms of cardiovascular disease (62.5%). The significance level for the two-sided Fisher&amp;#39;s exact test was 0.029. There were no other statistically significant differences between the groups. Conclusion: The results suggest that in case of mtDNA haplogroup H1background, T16189C polymorphism can have a protective effect on the risk of life-threatening conditions in cardiovascular diseases.</p></abstract><trans-abstract xml:lang="en"><p>Background: Mitochondria play a major role in providing cells with energy, but at the same time they are a source of free radicals that increase oxidative stress. It is known that the mitochondrial DNA genotype can affect the efficiency of oxygen uptake and ATP synthesis. In previous studies, it was shown that haplogroup H1 mtDNA may be a risk factor for the development of life-threatening conditions in cardiovascular diseases. The aim of the study: To identify mtDNA variants of the haplogroup H1 affecting the risk of acute cardiovascular events. Materials and methods: The complete sequence of mtDNAs belonging to the H1 haplogroup was sequenced in two groups: (1) individuals who died of heart disease before the age of 55 years, or who had repeated myocardial infarction or heart failure progression within one year of follow-up after myocardial infarction; (2) individuals over 60 years without symptoms of cardiovascular disease, or sutviving to 90 years. MtDNA haplotypes were revealed and classified by belonging to H1 subhaplogroups. Median-joining network was constructed in the program Network v5.0. Results: 13 different H1 subhaplogroups were identified in the studied samples. In the group with acute cardiovascular events, the incidence of T16189C polymorphism was 18.75%, compared with a sample of long-livers and individuals without symptoms of cardiovascular disease (62.5%). The significance level for the two-sided Fisher&amp;#39;s exact test was 0.029. There were no other statistically significant differences between the groups. Conclusion: The results suggest that in case of mtDNA haplogroup H1background, T16189C polymorphism can have a protective effect on the risk of life-threatening conditions in cardiovascular diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>mitochondrial DNA</kwd><kwd>cardiovascular diseases</kwd><kwd>genetic polymorphism</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mitochondrial DNA</kwd><kwd>cardiovascular diseases</kwd><kwd>genetic polymorphism</kwd></kwd-group></article-meta></front><back><ack><p>The study was supported by the Complex Program for Basic Research of SB RAS, &amp;laquo;Mitochondrial dysfunction and mitochondrial genome variability in the development of myocardial infarction and sudden cardiac death&amp;raquo;. For the study, the DNA samples from the collection &amp;laquo;Biobank of Northern Eurasia population&amp;raquo; were used. The study was performed using the equipment of&amp;nbsp; the Tomsk NRMC Center for the common use of scientific facilities &amp;laquo;Medical Genomics&amp;raquo;.</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Kenney MC, Chwa M, Atilano SR, et al. Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases. Biochim Biophys Acta. 2014 Feb;1842(2):208-19. DOI: 10.1016/j.bbadis.2013.10.016</mixed-citation></ref><ref id="B2"><mixed-citation>Malik D, Hsu T, Falatoonzadeh P, et al. Human retinal transmitochondrial cybrids with J or H mtDNA haplogroups respond differently to ultraviolet radiation: implications for retinal diseases. PLoS One [Internet]. 2014 [cited 2019 Sep 20];9(2):e99003. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099003. DOI: 10.1371/journal.pone.0099003</mixed-citation></ref><ref id="B3"><mixed-citation>Mueller EE, Brunner SM, Mayr JA, et al. Functional differences between mitochondrial haplogroup T and haplogroup H in HEK293 cybrid cells. PLoS One [Internet]. 2012 [cited 2019 Sep 20];7(12):e52367. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052367. DOI: 10.1371/journal.pone.0052367.</mixed-citation></ref><ref id="B4"><mixed-citation>Vasiliev VB. [Genetic basis of mitochondrial diseases]. S-Petersburg: Nestor-Istoriya; 2006. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Ng YS, Grady JP, Lax NZ, et al. Sudden adult death syndrome in m.3243A&amp;gt;G related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults. Eur Heart J. 2016 Aug 21;37(32):2552-9. DOI: 10.1093/eurheartj/ehv306</mixed-citation></ref><ref id="B6"><mixed-citation>Zhang Y, Guallar E, Ashar FN, et al. Association between mitochondrial DNA copy number and sudden cardiac death: findings from the Atherosclerosis Risk in Communities study (ARIC). Eur Heart J. 2017 Dec 7;38(46):3443-3448. DOI: 10.1093/eurheartj/ehx354</mixed-citation></ref><ref id="B7"><mixed-citation>Palacin M, Alvarez V, Martin M, et al. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H. Mitochondrion. 2011 Jan;11(1):176-81. DOI: 10.1016/j.mito.2010.09.004</mixed-citation></ref><ref id="B8"><mixed-citation>Fern&amp;aacute;ndez-Caggiano M, Barallobre-Barreiro J, Rego-P&amp;eacute;rez I, et al. Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy. PLoS One [Internet]. 2012 [cited 2019 sep 20];7(8):e44128. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0044128. DOI: 10.1371/journal.pone.0044128</mixed-citation></ref><ref id="B9"><mixed-citation>Golubenko MV, Salakhov RR, Makeeva OA, et al. [Mitochondrial DNA polymorphism association with myocardial infarction and prognostic signs for atherosclerosis]. Mol Biol (Mosk). 2015 Nov-Dec;49(6):968-76. Russian. DOI: 10.7868/S0026898415050080</mixed-citation></ref><ref id="B10"><mixed-citation>Golubenko MV, Salakhov RR, Shumakova TV, et al. [Mitochondrial DNA polymorphism and cardiovascular continuum diseases]. Medical Genetics. 2018;17(1):9-13. Russian. DOI: 10.25557/2073-7998.2018.01.9-13</mixed-citation></ref><ref id="B11"><mixed-citation>Abu-Amero KK, Al-Boudari OM, Mousa A, et al. The mitochondrial DNA variant 16189T&amp;gt;C is associated with coronary artery disease and myocardial infarction in Saudi Arabs. Genet Test Mol Biomarkers. 2010 Feb;14(1):43-7. DOI: 10.1089/gtmb.2009.0095</mixed-citation></ref><ref id="B12"><mixed-citation>Takagi K, Yamada Y, Gong JS, et al. Association of a 5178C--&amp;gt;A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals. Atherosclerosis. 2004 Aug;175(2):281-6. DOI: 10.1016/j.atherosclerosis.2004.03.008</mixed-citation></ref><ref id="B13"><mixed-citation>Hagen CM, Aidt FH, Hedley PL, et al. Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population PLoS One [Internet]. 2013 [cited 2019 Sep 15];8(8):e71904. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071904. DOI: 10.1371/journal.pone.0071904</mixed-citation></ref><ref id="B14"><mixed-citation>Zheikova TV. [The genetic basis for the regulation of oxidative stress: a relationship with ongoing life and coronary heart disease] [dissertation]. Tomsk: Research Institute of Medical Genetics; 2013. Russian.</mixed-citation></ref><ref id="B15"><mixed-citation>Stawski H, Bintz BJ, Burnside ES, et al. Preparing Whole Genome Human Mitochondrial DNA Libraries for Next Generation Sequencing (NGS) Using Illumina Nextera XT. Poster presentation at the 65th Annual American Academy of Forensic Sciences Conference. In: Proceedings of the American Academy of Forensic Sciences. Washington, D.C.; 2013.</mixed-citation></ref><ref id="B16"><mixed-citation>mtDNA-Server v 1.0.7. 2016: [updated 05 Dec 2017; cited 2018 Dec 01]. Available from: http://mtdna-server.uibk.ac.at/index.html.</mixed-citation></ref><ref id="B17"><mixed-citation>Hansi W, Forer L, Fuchsberger C, et al.mtDNA-Server: Next-Generation Sequencing Data Analysis of Human Mitochondrial DNA in the Cloud. Nucleic Acids Res. 2016 Jul 8;44(W1):W64-9.</mixed-citation></ref><ref id="B18"><mixed-citation>PhyloTreemt [Internet]. mtDNA tree Build 17: [updated 18 Feb 2016; cited 2018 Jan 12]. Available from: https://phylotree.org.</mixed-citation></ref><ref id="B19"><mixed-citation>van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009 Feb;30(2):E386-94. DOI: 10.1002/humu.20921</mixed-citation></ref><ref id="B20"><mixed-citation>Andrews RM, Kubacka I, Chinnery PF, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999 Oct;23(2):147. DOI: 10.1038/13779</mixed-citation></ref><ref id="B21"><mixed-citation>Liou CW, Lin TK, Chen JB, et al. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet. 2010 Nov;47(11):723-8. DOI: 10.1136/jmg.2010.077552</mixed-citation></ref><ref id="B22"><mixed-citation>Park KS, Chan JC, Chuang LM, et al. A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia. 2008 Apr;51(4):602-8. DOI: 10.1007/s00125-008-0933-z</mixed-citation></ref><ref id="B23"><mixed-citation>Ye Z, Gillson C, Sims M, et al. The association of the mitochondrial DNA OriB variant (16184-16193polycytosine tract) with type 2 diabetes in Europid populations. Diabetologia. 2013 Sep;56(9):1907-13. DOI: 10.1007/s00125-013-2945-6</mixed-citation></ref><ref id="B24"><mixed-citation>Mueller EE, Eder W, Ebner S, et al. The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One [Internet]. 2011 [cited 2019 Sep 15];6(1):e16455. DOI: 10.1371/journal.pone.0016455</mixed-citation></ref><ref id="B25"><mixed-citation>Behar DM, van Oven M, Rosset S, et al. A &amp;quot;Copernican&amp;quot; reassessment of the human mitochondrial DNA tree from its root. Am J Hum Genet. 2012 Apr 6;90(4):675-84. DOI: 10.1016/j.ajhg.2012.03.002</mixed-citation></ref><ref id="B26"><mixed-citation>Marinov GK, Wang YE, Chan D, et al. Evidence for site-specific occupancy of the mitochondrial genome by nuclear transcription factors. PLoS One [Internet]. 2014 [cited 2019 Sep 15];9(1):e84713. DOI: 10.1371/journal.pone.0084713</mixed-citation></ref><ref id="B27"><mixed-citation>Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016 Apr;8(4):796-809. DOI: 10.18632/aging.100943</mixed-citation></ref></ref-list></back></article>